{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T01:22:30Z","timestamp":1792891350683,"version":"4.5.0"},"reference-count":36,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2021.28544","type":"journal-article","created":{"date-parts":[[2021,10,17]],"date-time":"2021-10-17T13:47:08Z","timestamp":1634478428000},"page":"e2128544","source":"Crossref","is-referenced-by-count":127,"title":["Comparison of New Pharmacologic Agents With Triptans for Treatment of Migraine"],"prefix":"10.1001","volume":"4","author":[{"given":"Chun-Pai","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Neurology, Kuang Tien General Hospital, Taichung, Taiwan"},{"name":"Department of Nutrition, Hungkuang University, Taichung, Taiwan,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Sung","family":"Liang","sequence":"additional","affiliation":[{"name":"Beitou Branch, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Mao","family":"Chang","sequence":"additional","affiliation":[{"name":"Center for Traditional Medicine, Taipei Veterans General Hospital, Taipei, Taiwan"},{"name":"College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan"},{"name":"Institute of Traditional Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Chia","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Healthcare Administration, Asia University, Taichung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Hsuan","family":"Shih","sequence":"additional","affiliation":[{"name":"Institute of Traditional Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan"},{"name":"Department of Chinese Medicine, Cheng Hsin General Hospital, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Chain","family":"Yau","sequence":"additional","affiliation":[{"name":"Department of Biomedical Imaging and Radiological Sciences, National Yang Ming Chiao Tung, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Tung","family":"Tang","sequence":"additional","affiliation":[{"name":"College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan"},{"name":"Division of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taichung, Taiwan"},{"name":"PhD Program in Translational Medicine and Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuu-Jiun","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan"},{"name":"Department of Neurology, Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan"},{"name":"Brain Research Center, National Yang Ming Chiao Tung University, Taipei, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,10,11]]},"reference":[{"issue":"8","key":"zoi210829r1","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1046\/j.1468-2982.2002.00404.x","article-title":"Triptans (serotonin, 5-HT1B\/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials.","volume":"22","author":"Ferrari","year":"2002","journal-title":"Cephalalgia"},{"issue":"10127","key":"zoi210829r2","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/S0140-6736(18)30478-1","article-title":"Migraine.","volume":"391","author":"Dodick","year":"2018","journal-title":"Lancet"},{"key":"zoi210829r3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1129-2377-15-48","article-title":"Treatment adherence among new triptan users: a 2-year cohort study in Taiwan.","volume":"15","author":"Chen","year":"2014","journal-title":"J Headache Pain"},{"issue":"7","key":"zoi210829r4","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1093\/brain\/awz134","article-title":"Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine.","volume":"142","author":"Goadsby","year":"2019","journal-title":"Brain"},{"issue":"24","key":"zoi210829r5","doi-asserted-by":"publisher","first-page":"e2222","DOI":"10.1212\/WNL.0000000000006641","article-title":"Lasmiditan is an effective acute treatment for migraine: a phase 3 randomized study.","volume":"91","author":"Kuca","year":"2018","journal-title":"Neurology"},{"issue":"23","key":"zoi210829r6","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1056\/NEJMoa1813049","article-title":"Ubrogepant for the treatment of migraine.","volume":"381","author":"Dodick","year":"2019","journal-title":"N Engl J Med"},{"issue":"19","key":"zoi210829r7","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1001\/jama.2019.16711","article-title":"Effect of ubrogepant vs placebo on pain and the most bothersome associated symptom in the acute treatment of migraine: the ACHIEVE II randomized clinical trial.","volume":"322","author":"Lipton","year":"2019","journal-title":"JAMA"},{"key":"zoi210829r8","first-page":"1336","article-title":"Efficacy, safety, and tolerability of rimegepant 75 mg, an oral CGRP receptor antagonist, for the acute treatment of migraine: results from a double-blind, randomized, placebo-controlled trial, study 301.","volume":"58","year":"2018","journal-title":"Headache"},{"issue":"2","key":"zoi210829r9","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/NEJMoa1811090","article-title":"Rimegepant, an oral calcitonin gene-related peptide receptor antagonist, for migraine.","volume":"381","author":"Lipton","year":"2019","journal-title":"N Engl J Med"},{"issue":"10200","key":"zoi210829r10","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/S0140-6736(19)31606-X","article-title":"Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial.","volume":"394","author":"Croop","year":"2019","journal-title":"Lancet"},{"issue":"11","key":"zoi210829r11","doi-asserted-by":"publisher","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"zoi210829r12","article-title":"The International Classification of Headache Disorders, 3rd edition.","author":"Headache Classification Committee of the International Headache Society (IHS)","journal-title":"Cephalalgia"},{"issue":"10","key":"zoi210829r13","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/ijcp.2004.58.issue-10","article-title":"Efficacy and tolerability of sumatriptan tablets administered during the mild-pain phase of menstrually associated migraine.","volume":"58","author":"Landy","year":"2004","journal-title":"Int J Clin Pract"},{"issue":"6","key":"zoi210829r14","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/hed.2006.46.issue-6","article-title":"Efficacy of rizatriptan 10 mg administered early in a migraine attack.","volume":"46","author":"Cady","year":"2006","journal-title":"Headache"},{"key":"zoi210829r15","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials.","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"2","key":"zoi210829r16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial.","volume":"64","author":"Salanti","year":"2011","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"zoi210829r17","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1001\/archneur.1996.00550020092020","article-title":"A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine.","volume":"53","author":"Winner","year":"1996","journal-title":"Arch Neurol"},{"issue":"7","key":"zoi210829r18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069930","article-title":"A re-analysis of the Cochrane Library data: the dangers of unobserved heterogeneity in meta-analyses.","volume":"8","author":"Kontopantelis","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"zoi210829r19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1136\/jnnp-2020-323870","article-title":"Cognitive effects and acceptability of non-invasive brain stimulation on Alzheimer\u2019s disease and mild cognitive impairment: a component network meta-analysis.","volume":"92","author":"Chu","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"zoi210829r20","journal-title":"Cephalalgia"},{"issue":"2-3","key":"zoi210829r21","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0014-2999(99)00026-6","article-title":"Characterisation of the 5-HT receptor binding profile of eletriptan and kinetics of [3H]eletriptan binding at human 5-HT1B and 5-HT1D receptors.","volume":"368","author":"Napier","year":"1999","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"zoi210829r22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0014-2999(01)01151-7","article-title":"Serotonergic effects and extracellular brain levels of eletriptan, zolmitriptan and sumatriptan in rat brain.","volume":"425","author":"Johnson","year":"2001","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"zoi210829r23","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1046\/j.1460-9568.2000.00299.x","article-title":"Effects of eletriptan on the peptidergic innervation of the cerebral dura mater and trigeminal ganglion, and on the expression of c-fos and c-jun in the trigeminal complex of the rat in an experimental migraine model.","volume":"12","author":"Knyih\u00e1r-Csillik","year":"2000","journal-title":"Eur J Neurosci"},{"issue":"5","key":"zoi210829r24","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1017\/S0317167100118943","article-title":"Canadian Headache Society Guideline: acute drug therapy for migraine headache.","volume":"40","author":"Worthington","year":"2013","journal-title":"Can J Neurol Sci"},{"issue":"613","key":"zoi210829r25","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3399\/bjgp13X670895","article-title":"Diagnosis and management of headaches in young people and adults: NICE guideline.","volume":"63","author":"Kennis","year":"2013","journal-title":"Br J Gen Pract"},{"issue":"1","key":"zoi210829r26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s10194-020-01138-x","article-title":"Short-term efficacy and safety of lasmiditan, a novel 5-HT1F receptor agonist, for the acute treatment of migraine: a systematic review and meta-analysis.","volume":"21","author":"Hou","year":"2020","journal-title":"J Headache Pain"},{"issue":"3","key":"zoi210829r27","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1177\/0333102418768095","article-title":"CGRP\u2014a target for acute therapy in migraine: clinical data.","volume":"39","author":"Messina","year":"2019","journal-title":"Cephalalgia"},{"issue":"2","key":"zoi210829r28","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s13311-018-0617-4","article-title":"Targeted CGRP small molecule antagonists for acute migraine therapy.","volume":"15","author":"Holland","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"8","key":"zoi210829r32","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1111\/head.v60.8","article-title":"Pain freedom at 2 to 8 hours with lasmiditan: a comparison with rimegepant and ubrogepant.","volume":"60","author":"Doty","year":"2020","journal-title":"Headache"},{"issue":"2","key":"zoi210829r33","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3988\/jcn.2012.8.2.89","article-title":"Sensitization of the trigeminovascular pathway: perspective and implications to migraine pathophysiology.","volume":"8","author":"Bernstein","year":"2012","journal-title":"J Clin Neurol"},{"issue":"7","key":"zoi210829r34","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1212\/WNL.0000000000001256","article-title":"Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine.","volume":"84","author":"Lipton","year":"2015","journal-title":"Neurology"},{"issue":"8","key":"zoi210829r35","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/j.1468-2982.2008.01819.x","article-title":"The acute treatment of episodic and chronic migraine in the USA.","volume":"29","author":"Bigal","year":"2009","journal-title":"Cephalalgia"},{"issue":"1","key":"zoi210829r36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/head.2015.55.issue-1","article-title":"The acute treatment of migraine in adults: the American Headache Society evidence assessment of migraine pharmacotherapies.","volume":"55","author":"Marmura","year":"2015","journal-title":"Headache"},{"key":"zoi210829r29","unstructured":"U.S. Food and Drug Administration. FDA approves new treatment for adults with migraine. Published December 23, 2019. Accessed October 15, 2020. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-treatment-adults-migraine"},{"key":"zoi210829r30","unstructured":"U.S. Food and Drug Administration. NDA approval: NDA 212728. Published February 27, 2020. Accessed October 16, 2020. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/2020\/212728Orig1s000ltr.pdf"},{"key":"zoi210829r31","unstructured":"Institute for Clinical and Economic Review. Migraine: acute therapies. Accessed October 19, 2020. https:\/\/icer-review.org\/material\/acute-migraine-evidence- report\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2784777\/yang_2021_oi_210829_1632853459.97319.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,17]],"date-time":"2021-10-17T13:47:44Z","timestamp":1634478464000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2784777"}},"subtitle":["A Systematic Review and Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2021,10,11]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.28544","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,11]]}}}